Related Experiment Video
Updated: May 28, 2026

Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP)
Published on: June 14, 2021
Bilirubin adsorption properties of water-soluble adsorbents with different cyclodextrin cavities in plasma dialysis
Zhi Wang1, Yaming Cao, Houliang Wei
1School of Life Science and Biotechnology, Dalian University of Technology, Dalian, China.
Abstract:
In this study, we explored the use of α-, β- or γ-cyclodextrin (CD)-grafted polyethyleneimine (PEI) as water-soluble adsorbent for removing excess plasma bilirubin. To evaluate the bilirubin-binding capacity of these adsorbents, bovine serum albumin (BSA) solution or plasma with high level of bilirubin were dialyzed against CD-PEI-spiked dialysate. In BSA solution with an initial biliurbin concentration of 171.5mg/L, α-CD-PEI, β-CD-PEI and γ-CD-PEI achieved adsorption capacities of 2.5, 5.8 and 3.8 mg/g, respectively. In a plasma dialysis system, 45.6% of bilirubin (260 mg/L) was removed from 200 mL plasma by 1L dialysate spiked with 10mg/mL β-CD-PEI, which was significantly higher than that removed by the same volume of BSA-spiked dialysate (P<0.05), demonstrating the strong bilirubin-binding ability of β-CD-PEI. The key feature of bilirubin adsorption was related to the CD functional group, not the PEI matrix. Subsequent molecular docking study indicated that the size of CD cavity could affect the affinity energy of CD-bilirubin complex. The cavity of β-CD was most suitable for accommodating the pyrrole rings of bilirubin. The inclusion complex of bilirubin and β-CD in the molar ratio of 1:2 was more logical in terms of affinity energy. All the results demonstrated the potential of β-CD-PEI (water-soluble adsorbent) as an effective agent for removing of bilirubin from plasma in dialysis system.
Related Concept Videos
Dialysis
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Drug Distribution: Plasma Protein Binding
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted less...

